WallStreetZenWallStreetZen

NASDAQ: ANTX
An2 Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for ANTX

Based on 3 analysts offering 12 month price targets for An2 Therapeutics Inc.
Min Forecast
$2.00+0.5%
Avg Forecast
$5.00+151.26%
Max Forecast
$7.00+251.76%

Should I buy or sell ANTX stock?

Based on 3 analysts offering ratings for An2 Therapeutics Inc.
Hold
Strong Buy
0 analysts 0%
Buy
1 analysts 33.33%
Hold
2 analysts 66.67%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ANTX stock forecasts and price targets.

ANTX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-05-16
lockedlocked$00.00+00.00%2024-04-02
lockedlocked$00.00+00.00%2024-02-13

1 of 1

Forecast return on equity

Is ANTX forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
27.85%

Forecast return on assets

Is ANTX forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

ANTX revenue forecast

What is ANTX's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$72.7M
Avg 2 year Forecast
$217.0M
Avg 3 year Forecast
$390.0M

ANTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ANTX$1.99$5.00+151.26%Hold
LVTX$2.26$6.00+165.49%Buy
NTRB$5.45N/AN/A
CELU$3.11N/AN/A
TSBX$2.61N/AN/A
View Top Biotech Stocks

An2 Therapeutics Stock Forecast FAQ

Is An2 Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: ANTX) stock is to Hold ANTX stock.

Out of 3 analysts, 0 (0%) are recommending ANTX as a Strong Buy, 1 (33.33%) are recommending ANTX as a Buy, 2 (66.67%) are recommending ANTX as a Hold, 0 (0%) are recommending ANTX as a Sell, and 0 (0%) are recommending ANTX as a Strong Sell.

If you're new to stock investing, here's how to buy An2 Therapeutics stock.

What is ANTX's revenue growth forecast for 2026-2028?

(NASDAQ: ANTX) An2 Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.36%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.64%.

An2 Therapeutics's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast ANTX's revenue for 2026 to be $2,168,571,208, with the lowest ANTX revenue forecast at $2,168,571,208, and the highest ANTX revenue forecast at $2,168,571,208. On average, 1 Wall Street analysts forecast ANTX's revenue for 2027 to be $6,472,901,680, with the lowest ANTX revenue forecast at $6,472,901,680, and the highest ANTX revenue forecast at $6,472,901,680.

In 2028, ANTX is forecast to generate $11,633,325,600 in revenue, with the lowest revenue forecast at $11,633,325,600 and the highest revenue forecast at $11,633,325,600.

What is ANTX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: ANTX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is ANTX's Price Target?

According to 3 Wall Street analysts that have issued a 1 year ANTX price target, the average ANTX price target is $5.00, with the highest ANTX stock price forecast at $7.00 and the lowest ANTX stock price forecast at $2.00.

On average, Wall Street analysts predict that An2 Therapeutics's share price could reach $5.00 by May 16, 2025. The average An2 Therapeutics stock price prediction forecasts a potential upside of 151.26% from the current ANTX share price of $1.99.

What is ANTX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: ANTX) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.